{{Rsnum
|rsid=2467853
|Gene=SPATA5L1
|Chromosome=15
|position=45406595
|Orientation=plus
|GMAF=0.3113
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=SPATA5L1
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 9.4 | 46.9 | 43.8
| HCB | 0.0 | 0.0 | 0.0
| JPT | 0.0 | 0.0 | 0.0
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19430482
|Trait=Renal function and chronic kidney disease
|Title=Multiple loci associated with indices of renal function and chronic kidney disease
|RiskAllele=G
|Pval=6E-14
|OR=0.01
|ORtxt=[0.009-0.017] ml/min/1.73m2 decrease
|OA=1
}}

{{PMID Auto
|PMID=20222955
|Title=A meta-analysis of genome-wide data from five European isolates reveals an association of COL22A1, SYT1, and GABRR2 with serum creatinine level.
|OA=1
}}

{{PMID Auto
|PMID=20686651
|Title=Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2467853
|overall_frequency_n=84
|overall_frequency_d=122
|overall_frequency=0.688525
|n_genomes=47
|n_genomes_annotated=0
|n_haplomes=78
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}